Handok's Amaryl-M gets positive response in Indonesia

Handok Pharm's homegrown anti-diabetic agent Amaryl-M, a combined medicine of glimepiride and metformin, received favorable response from Indonesian doctors at a launching symposium held in Jakarta in March 1.

Amaryl is effective as initial drug therapy. In patients where monotherapy with Amaryl or metformin has not produced adequate glycemic control, Amaryl-M hasa synergistic effect, since ...